Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Cingulate Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.cingulate.comAI Executive Summary
AI-powered analysis of 8-K filing content
Cingulate Inc. appointed Matthew N. Brams as Executive Vice President and Chief Medical Officer on September 30, 2026, following an amendment to his employment agreement effective January 1, 2026. This leadership appointment is intended to strengthen the company's medical strategy and clinical development capabilities in the biopharmaceutical sector.
Key Takeaways
Matthew N. Brams elevated to Executive Vice President and Chief Medical Officer role
Employment agreement amendment No. 2 executed, effective retroactively from January 1, 2026
2 more takeaways
Filing Overview
What This Means
Cingulate Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.